Background

The safety, effectiveness and cost-effectiveness of medicines are controlled by regulatory and advisory processes, for more information click here.

NHS Grampian recognises that there will be times when prescribers may wish to prescribe a medicine that:

  • has not received a marketing authorisation (not been licensed),
  • is to be used in clinical circumstances outside of the marketing authorisation,
  • is licensed but is awaiting SMC advice,
  • is licensed but where SMC/Healthcare Improvement Scotland has advised the medicine should not be used in NHS Scotland.
  • is contrary to NHS Grampian's local policy.

The processes and associated guidance describe NHS Grampian's policies for the prescribing of medicines in such circumstances, specifically prescribing of:

  • licensed non-formulary medicines
  • unlicensed medicines
  • off-label medicines
  • licensed medicines which the SMC or NHS Healthcare Improvement Scotland have recommended should not be used in NHS Scotland
  • licensed medicines which are awaiting SMC or NHS Healthcare Improvement Scotland guidance
  • licensed medicines for individual patients contrary to agreed local NHS Grampian policies.

NHS Grampian makes a distinction between requests to prescribe:

  • for groups of patients which normally require a submission to the Grampian Formulary Group (see group requests)
  • for single patients where a number of different routes are available dependant on the circumstances of the request (see flowchart for more information).

Guidance documents

Published: 01/10/2020 12:11